CREDID COVID-19 ADAPTIVE PLATFORM - RANDOMISED CLINICAL TRIALS
- Funded by Lundbeck Foundation
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
2020Known Financial Commitments (USD)
$750,000Funder
Lundbeck FoundationResearch Location
DenmarkLead Research Institution
Hvidovre HospitalResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Prophylactic use of treatmentsSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Randomized Controlled TrialBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
It will probably take years to develop an actual vaccine for the COVID-19 virus. A research group at Hvidovre Hospital will therefore investigate whether well-known drugs such as hydroxychloroquine, plasma from people who have recovered from the virus, IL-6 antagonists and baricitinib could have a positive effect on adults with COVID-19 pneumonia.